← Open Payments lookup

VALERIE BOTSCHELLER: Open Payments

NPI 1649781030 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,638 in 149 payments from 18 companies in 2025. Trend: 2023 $2,844 · 2024 $3,844 · 2025 $3,638

Food & beverage: $3,638
CompanyPaymentsAmount
ABBVIE INC.28$761
Janssen Biotech, Inc.15$599
QOL Medical, LLC21$532
Phathom Pharmaceuticals, Inc.25$251
Takeda Pharmaceuticals U.S.A., Inc.11$249
Regeneron Healthcare Solutions, Inc.9$190
Madrigal Pharmaceuticals5$185
GENZYME CORPORATION7$172
Novo Nordisk Inc3$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$135

Products named: TREMFYA, Sucraid, DUPIXENT, VOQUEZNA, SKYRIZI, MAVYRET, ENTYVIO, REZDIFFRA.

Industry payments across MD — which companies pay providers there.